Cargando…
Current therapy and development of therapeutic agents for lung cancer
In the past decades, great progress has been made for the prevention and treatment of lung cancer. Yet, lung cancer remains as the leading cause of cancer death worldwide. In this manuscript, we describe the current genetic and molecular characterization of lung cancer subtypes, review up-to-date tr...
Autores principales: | Wang, Zilai, Kim, Jiyeon, Zhang, Pin, Galvan Achi, Jazmin M., Jiang, Yuwei, Rong, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120308/ https://www.ncbi.nlm.nih.gov/pubmed/37193130 http://dx.doi.org/10.1016/j.cellin.2022.100015 |
Ejemplares similares
-
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses
por: Cooper, Laura, et al.
Publicado: (2022) -
SARS-CoV-2 cell entry and targeted antiviral development
por: Chen, Zinuo, et al.
Publicado: (2021) -
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
por: Bao, Rudi, et al.
Publicado: (2011) -
Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
por: Achi, Ijeoma Theresa, et al.
Publicado: (2022) -
Current and developing therapeutic agents in the treatment of Chagas disease
por: Apt, Werner
Publicado: (2010)